Rheumatology practices don’t lose revenue because they’re billing incorrectly. They lose it because the revenue cycle wasn’t designed for the way rheumatology actually works — long treatment cycles, repeat authorizations, specialty biologics, and payers with long institutional memories.
When a Central Florida multi-location rheumatology practice came to EMPClaims, their denial rate had climbed to 40%. Not from careless billing. From process failures compounding quietly over time.
Here’s what we found, what we changed, and what it produced.
When EMPClaims began auditing the practice’s revenue operations, the surface-level data told one story: a high denial rate on specialty procedures. But the underlying cause was more specific.
Payers remember patterns. When the same CPT codes are billed repeatedly — as they must be in rheumatology — any inconsistency in coding, authorization status, or documentation creates a repeating target. Payers don’t just deny a single claim. They build a behavioral profile.
What our team found across this practice’s locations:
None of these were billing mistakes in the traditional sense. They were process failures — structural gaps that grew more expensive with every month they went unaddressed.
The first intervention was rebuilding how the practice tracked prior authorizations across its locations. EMPClaims implemented structured authorization lifecycle management: approvals obtained before service, approval limits tracked visit-to-visit, and expiring or missing authorizations surfaced before claims were submitted.
For a practice billing infusion services and specialty biologics, this alone eliminated a significant category of preventable denials.
Our certified coders reviewed the practice’s CPT patterns across providers and encounter types. The goal wasn’t just accuracy on any given claim — it was eliminating the variation that gives payers a reason to scrutinize.
For rheumatology, where the same patient returns for the same treatment across dozens of visits per year, coding consistency is a revenue protection strategy, not a compliance checkbox.
EMPClaims introduced payer-specific AR workflows with structured denial analysis. Instead of chasing each denied claim individually, the team identified which denial categories were repeating — and traced them back to their source. Front-end corrections followed.
Active providers were audited against payer enrollment records. Credentialing gaps were closed and ongoing re-credentialing was incorporated into standard operations, preventing the enrollment lapses that silently block reimbursement at multi-location practices.
Rheumatology revenue is built on consistency and discipline, not just speed. Payers remember patterns — and so do we.
Within the engagement period, the practice’s denial rate dropped from 40% to 20–25% — a reduction of approximately 50%.
A reduction of approximately 50% within the engagement period.
| Metric | Before EMPClaims | After EMPClaims |
|---|---|---|
| Denial Rate | 40% | 20–25% |
| Authorization-Related Denials | Recurring, untracked | Proactively prevented |
| Coding Consistency | Variable across providers | Standardized across locations |
| AR Follow-Up | Reactive | Structured, payer-specific workflows |
A 50% reduction in denial rate doesn’t happen because you bill harder. It happens because you change the underlying conditions that produce denials.
For rheumatology specifically, that means:
Rheumatology revenue is built on consistency and discipline — not speed.
EMPClaims works with rheumatology practices to identify and eliminate the process failures driving repeat denials. If your denial rate is climbing — or if you suspect the same claim categories are failing month after month — we can show you exactly where the breakdown is.
